Human Rights Measure
Rapid Responses in the Context of COVID-19 – Medicated Voluntary Interruption of Pregnancy (VIP) in the 8th and 9th Week of Amenhorrhea Outside of Hospital (Résponses Rapides dans le Cadre du COVID-19 – Interruption Volontaire de Grossesse (IVG) Médicamenteuse à la 8ème et à la 9ème Semaine d’Aménhorrhée (SA) Hors Milieu Hospitalier)
Date Enacted: April 2020
Country: France
Region: Europe and Central Asia
Noting that “it is imperative in the current epidemic situation to guarantee a response to requests for abortion, under conditions that do not lead to exceeding the legal deadlines for abortion, while limiting the exposure of patients and professionals to COVID-19, and conserving the resources of health establishments,” the French National Authority of Health developed protocols to enable “a medical abortion to be performed in the 8th and 9th week of amenorrhea outside a health facility” by taking mifepristone and misoprostol (in contrast to regulations that did not allow for medical abortion in the 8th and 9th week of amenorrhea outside a health facility prior to the COVID-19 pandemic).
